MUELLER PETER 4
4 · BioXcel Therapeutics, Inc. · Filed May 26, 2020
Insider Transaction Report
Form 4
MUELLER PETER
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-05-21+20,000→ 20,000 totalExercise: $49.74Exp: 2030-05-21→ Common Stock (20,000 underlying) - Award
Stock Option (Right to Buy)
2020-05-21+5,000→ 5,000 totalExercise: $49.74Exp: 2030-05-21→ Common Stock (5,000 underlying)
Footnotes (1)
- [F1]The option will vest in full and become exercisable on the earlier of the first anniversary of the grant date or the day immediately prior to the date of the next BioXcel Therapeutics, Inc. annual meeting of stockholders, subject to the Reporting Person's continued service through such vesting date.